全球COVID-19大流行中的整形外科实践:印度共识
该印度共识基于ICMR推荐及印度主要整形重建中心经验制定,将需整形外科服务的患者按紧急程度分为急性、亚急性、慢性、晚期四类,并针对每类给出独立指南。核心结论是在COVID-19大流行下,缺乏针对整形外科患者的明确指南,推荐采用「延迟保守治疗」策略,以平衡患者整形问题风险与手术团队COVID-19暴露风险。
要点
- 急性病例需在24-48小时内干预,亚急性在3-10天内,慢性优选1个月内,晚期在6个月内。
- 分类依据手术紧迫性与优先级,并权衡手术风险及 inadvertent COVID-19暴露风险。
- 推荐「延迟保守治疗」策略,基于科学证据并考虑资源限制与感染风险。
核心结论
- 当前缺乏针对整形外科患者的明确COVID-19指南,共识推荐采用「延迟保守治疗」策略以平衡整形问题风险与COVID-19暴露风险。
研究设计与样本
- 基于ICMR及政府/非政府来源的COVID-19指南,结合印度主要整形重建中心经验制定共识指南。
主要发现
- 将整形外科患者按紧急程度分为急性(24-48小时)、亚急性(3-10天)、慢性(1个月内)、晚期(6个月内)四类。
关键数值与推荐
- 急性病例需在24-48小时内干预;亚急性在3-10天内;慢性优选1个月内;晚期在6个月内。
临床怎么用
- 整形外科医生应根据患者分类及手术紧迫性与COVID-19暴露风险的权衡,决定干预时机。
局限性
- 共识基于印度特定背景与资源限制,可能不适用于其他地区。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The COVID-19 pandemic having spread globally has profound implications on medical and surgical care, which is given by the health care providers. At this time, though there are guidelines and recommendations for medical management of these patients, there is a lack of guidance on how a plastic surgeon should approach the COVID-19 suspect or infected patient who presents either in an elective or emergency setting. We aim to provide a consensus guideline based on the current recommendations of the Indian Council of Medical Research (ICMR) and the pooled experience of the major centers performing plastic and reconstructive surgery in India. METHODS: The current guidelines and recommendations on the COVID-19 pandemic were studied from both government and nongovernment sources including ICMR. The problems in the specialty of plastic surgery were categorized into four groups and for each group, separate and individual guidelines have been formulated. GUIDELINES: Consensus guidelines have been formulated for the specialty of Plastic and Reconstructive surgery. The patients requiring plastic surgery service have been categorized into four groups of acute, subacute, chronic, and late category. Acute cases are the ones who require intervention within 24-48 h. Subacute cases are the ones who require intervention in the next 3-10 days, while the chronic are the ones who need plastic surgery preferably within a month. The late category are the ones who need surgery within the next six months. This has been done based on the urgency and priority of surgical intervention titrated against the risks of operating and inadvertently acquiring the exposure of COVID-19-positive patients. CONCLUSION: Currently, in the wake of COVID-19 pandemic, there are no clear guidelines specific to the vast majority of patients who come for a plastic surgery intervention. This puts the patients at risk due to the impending plastic surgery problem while at the same time it poses a risk of exposure to COVID-19 for the surgical team. Consensus guidelines are presented, to steer the plastic surgeon in his work, in the wake of COVID-19 crisis. The guidelines are based on firm scientific evidence from the reputed research and regulatory bodies and have been made in consonance with plastic surgery experts around the country, so that these practices best suit the needs of the patients, while being mindful of resource limitations and infection risks. The approach of "delayed conservative treatment" works best in the present case scenario.
引用
- Agarwal R, Singhal M, Shankhdhar VK, et al. Plastic surgery practices amidst global COVID-19 pandemic: Indian consensus. J Plast Reconstr Aesthet Surg. 2020. PMID: 32878726. doi:10.1016/j.bjps.2020.08.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。